Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Treating Gynecologic Malignancies with Selective Estrogen Receptor Downregulators (SERDs): Promise and Challenges.

Boisen MM, Andersen CL, Sreekumar S, Stern AM, Oesterreich S.

Mol Cell Endocrinol. 2015 Aug 11. pii: S0303-7207(15)30038-1. doi: 10.1016/j.mce.2015.04.035. [Epub ahead of print]

PMID:
26276546
2.

The potential role of Alu Y in the development of resistance to SN38 (Irinotecan) or oxaliplatin in colorectal cancer.

Lin X, Stenvang J, Rasmussen MH, Zhu S, Jensen NF, Tarpgaard LS, Yang G, Belling K, Andersen CL, Li J, Bolund L, Brünner N.

BMC Genomics. 2015 May 22;16:404. doi: 10.1186/s12864-015-1552-y.

3.

[Status and perspectives on chronic myeloproliferative neoplasm treatment].

Ocias LF, Holmström MO, Riley CH, Andersen CL, Rønnov-Jessen D, Starklint J, Frederiksen M, Steffensen MS, Bjerrum OW, Farmer S, Mourits-Andersen T, Hasselbalch HC, Larsen TS.

Ugeskr Laeger. 2015 May 4;177(19). pii: V12140652. Danish.

PMID:
25967090
4.

3'-UTR poly(T/U) repeat of EWSR1 is altered in microsatellite unstable colorectal cancer with nearly perfect sensitivity.

Kondelin J, Tuupanen S, Gylfe AE, Aavikko M, Renkonen-Sinisalo L, Järvinen H, Böhm J, Mecklin JP, Andersen CL, Vahteristo P, Pitkänen E, Aaltonen LA.

Fam Cancer. 2015 May 1. [Epub ahead of print]

PMID:
25930744
5.

Establishment and characterization of models of chemotherapy resistance in colorectal cancer: Towards a predictive signature of chemoresistance.

Jensen NF, Stenvang J, Beck MK, Hanáková B, Belling KC, Do KN, Viuff B, Nygård SB, Gupta R, Rasmussen MH, Tarpgaard LS, Hansen TP, Budinská E, Pfeiffer P, Bosman F, Tejpar S, Roth A, Delorenzi M, Andersen CL, Rømer MU, Brünner N, Moreira JM.

Mol Oncol. 2015 Jun;9(6):1169-85. doi: 10.1016/j.molonc.2015.02.008. Epub 2015 Feb 24.

PMID:
25759163
6.

Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery.

Reinert T, Schøler LV, Thomsen R, Tobiasen H, Vang S, Nordentoft I, Lamy P, Kannerup AS, Mortensen FV, Stribolt K, Hamilton-Dutoit S, Nielsen HJ, Laurberg S, Pallisgaard N, Pedersen JS, Ørntoft TF, Andersen CL.

Gut. 2015 Feb 4. pii: gutjnl-2014-308859. doi: 10.1136/gutjnl-2014-308859. [Epub ahead of print]

PMID:
25654990
7.

Association of the blood eosinophil count with hematological malignancies and mortality.

Andersen CL, Siersma VD, Hasselbalch HC, Vestergaard H, Mesa R, Felding P, Olivarius ND, Bjerrum OW.

Am J Hematol. 2015 Mar;90(3):225-9. doi: 10.1002/ajh.23916. Epub 2015 Jan 16.

PMID:
25488524
8.

Determinants of recurrence after intended curative resection for colorectal cancer.

Wilhelmsen M, Kring T, Jorgensen LN, Madsen MR, Jess P, Bulut O, Nielsen KT, Andersen CL, Nielsen HJ.

Scand J Gastroenterol. 2014 Dec;49(12):1399-408. doi: 10.3109/00365521.2014.926981. Epub 2014 Nov 5. Review.

PMID:
25370351
9.

[Screening methods for colorectal cancer can be improved.]

Rasmussen L, Jørgensen LN, Madsen MR, Vilandt J, Klærke M, Andersen J, Nielsen KT, Khalid A, Laurberg S, Andersen CL, Christensen IJ, Brünner N, Nielsen HJ.

Ugeskr Laeger. 2014 Mar 10;176(11B). pii: V09130545. Danish.

PMID:
25350810
10.

Similar strength of the NH···O and NH···S hydrogen bonds in binary complexes.

Andersen CL, Jensen CS, Mackeprang K, Du L, Jørgensen S, Kjaergaard HG.

J Phys Chem A. 2014 Nov 20;118(46):11074-82. doi: 10.1021/jp5086679. Epub 2014 Nov 10.

PMID:
25340722
11.

A dual program for translation regulation in cellular proliferation and differentiation.

Gingold H, Tehler D, Christoffersen NR, Nielsen MM, Asmar F, Kooistra SM, Christophersen NS, Christensen LL, Borre M, Sørensen KD, Andersen LD, Andersen CL, Hulleman E, Wurdinger T, Ralfkiær E, Helin K, Grønbæk K, Orntoft T, Waszak SM, Dahan O, Pedersen JS, Lund AH, Pilpel Y.

Cell. 2014 Sep 11;158(6):1281-92. doi: 10.1016/j.cell.2014.08.011.

PMID:
25215487
12.

Identification of 33 candidate oncogenes by screening for base-specific mutations.

Tuupanen S, Hänninen UA, Kondelin J, von Nandelstadh P, Cajuso T, Gylfe AE, Katainen R, Tanskanen T, Ristolainen H, Böhm J, Mecklin JP, Järvinen H, Renkonen-Sinisalo L, Andersen CL, Taipale M, Taipale J, Vahteristo P, Lehti K, Pitkänen E, Aaltonen LA.

Br J Cancer. 2014 Oct 14;111(8):1657-62. doi: 10.1038/bjc.2014.429. Epub 2014 Aug 12.

PMID:
25117815
13.

Putative cis-regulatory drivers in colorectal cancer.

Ongen H, Andersen CL, Bramsen JB, Oster B, Rasmussen MH, Ferreira PG, Sandoval J, Vidal E, Whiffin N, Planchon A, Padioleau I, Bielser D, Romano L, Tomlinson I, Houlston RS, Esteller M, Orntoft TF, Dermitzakis ET.

Nature. 2014 Aug 7;512(7512):87-90. doi: 10.1038/nature13602. Epub 2014 Jul 23.

PMID:
25079323
14.

The Copenhagen Primary Care Differential Count (CopDiff) database.

Andersen CL, Siersma VD, Karlslund W, Hasselbalch HC, Felding P, Bjerrum OW, de Fine Olivarius N.

Clin Epidemiol. 2014 Jun 12;6:199-211. doi: 10.2147/CLEP.S60991. eCollection 2014.

15.

Risk of lymphoma and solid cancer among patients with rheumatoid arthritis in a primary care setting.

Andersen CL, Lindegaard H, Vestergaard H, Siersma VD, Hasselbalch HC, de Fine Olivarius N, Bjerrum OW, Junker P.

PLoS One. 2014 Jun 10;9(6):e99388. doi: 10.1371/journal.pone.0099388. eCollection 2014.

16.

Eosinophilia in routine blood samples as a biomarker for solid tumor development - A study based on the Copenhagen Primary Care Differential Count (CopDiff) Database.

Andersen CL, Siersma VD, Hasselbalch HC, Lindegaard H, Vestergaard H, Felding P, de Fine Olivarius N, Bjerrum OW.

Acta Oncol. 2014 Sep;53(9):1245-50. doi: 10.3109/0284186X.2014.887857. Epub 2014 Mar 10.

PMID:
24913152
17.

Functional screening identifies miRNAs influencing apoptosis and proliferation in colorectal cancer.

Christensen LL, Holm A, Rantala J, Kallioniemi O, Rasmussen MH, Ostenfeld MS, Dagnaes-Hansen F, Øster B, Schepeler T, Tobiasen H, Thorsen K, Sieber OM, Gibbs P, Lamy P, Hansen TF, Jakobsen A, Riising EM, Helin K, Lubinski J, Hagemann-Madsen R, Laurberg S, Ørntoft TF, Andersen CL.

PLoS One. 2014 Jun 3;9(6):e96767. doi: 10.1371/journal.pone.0096767. eCollection 2014.

18.

Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue.

Hedegaard J, Thorsen K, Lund MK, Hein AM, Hamilton-Dutoit SJ, Vang S, Nordentoft I, Birkenkamp-Demtröder K, Kruhøffer M, Hager H, Knudsen B, Andersen CL, Sørensen KD, Pedersen JS, Ørntoft TF, Dyrskjøt L.

PLoS One. 2014 May 30;9(5):e98187. doi: 10.1371/journal.pone.0098187. eCollection 2014.

19.

Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat.

Andersen CL, Bjørn ME, McMullin MF, Harrison C, Samuelsson J, Ejerblad E, Zweegman S, Fernandes S, Bareford D, Knapper S, Löfvenberg E, Linder O, Andreasson B, Ahlstrand E, Jensen MK, Bjerrum OW, Vestergaard H, Larsen H, Klausen TW, Mourits-Andersen T, Skov V, Thomassen M, Kruse T, Grønbæk K, Hasselbalch HC.

Leuk Res. 2014 Jul;38(7):816-21. doi: 10.1016/j.leukres.2014.04.002. Epub 2014 Apr 14.

PMID:
24836761
20.

Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation.

Maimon A, Mogilevsky M, Shilo A, Golan-Gerstl R, Obiedat A, Ben-Hur V, Lebenthal-Loinger I, Stein I, Reich R, Beenstock J, Zehorai E, Andersen CL, Thorsen K, Orntoft TF, Davis RJ, Davidson B, Mu D, Karni R.

Cell Rep. 2014 Apr 24;7(2):501-13. doi: 10.1016/j.celrep.2014.03.041. Epub 2014 Apr 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk